Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
45 more patients discontinued, that’s 65% more than placebo and nearly 4% of participants. Why is that not significant?
I don’t think we can be so dismissive of >5x elevations. Not a clinician but the math seems like a larger absolute number of patients would experience liver issues than would avoid cardiac events.
For patients who discontinued, how do we know it was transient?
